ChemSpider 2D Image | 4-{[(7-bromo-4-hydroxy-2-methylquinazolin-6-yl)methyl](prop-2-yn-1-yl)amino}-N-(pyridin-3-ylmethyl)benzamide | C26H22BrN5O2

4-{[(7-bromo-4-hydroxy-2-methylquinazolin-6-yl)methyl](prop-2-yn-1-yl)amino}-N-(pyridin-3-ylmethyl)benzamide

  • Molecular FormulaC26H22BrN5O2
  • Average mass516.389 Da
  • Monoisotopic mass515.095703 Da
  • ChemSpider ID8046884

More details:

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

4-{[(7-Brom-2-methyl-4-oxo-1,4-dihydro-6-chinazolinyl)methyl](2-propin-1-yl)amino}-N-(3-pyridinylmethyl)benzamid [German] [ACD/IUPAC Name]
4-{[(7-Bromo-2-methyl-4-oxo-1,4-dihydro-6-quinazolinyl)methyl](2-propyn-1-yl)amino}-N-(3-pyridinylmethyl)benzamide [ACD/IUPAC Name]
4-{[(7-Bromo-2-méthyl-4-oxo-1,4-dihydro-6-quinazolinyl)méthyl](2-propyn-1-yl)amino}-N-(3-pyridinylméthyl)benzamide [French] [ACD/IUPAC Name]
4-{[(7-bromo-4-hydroxy-2-methylquinazolin-6-yl)methyl](prop-2-yn-1-yl)amino}-N-(pyridin-3-ylmethyl)benzamide
Benzamide, 4-[[(7-bromo-1,4-dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl]-2-propyn-1-ylamino]-N-(3-pyridinylmethyl)- [ACD/Index Name]
[206275-15-2] [RN]
206275-15-2 [RN]
4-(((7-bromo-2-methyl-4-oxo-1,4-dihydroquinazolin-6-yl)methyl)(prop-2-yn-1-yl)amino)-N-(pyridin-3-ylmethyl)benzamide
4-(((7-bromo-2-methyl-4-oxo-3,4-dihydroquinazolin-6-yl)methyl)(prop-2-yn-1-yl)amino)-N-(pyridin-3-ylmethyl)benzamide
4-?[[(7-?bromo-?3,?4-?dihydro-?2-?methyl-?4-?oxo-?6-?quinazolinyl)?methyl]?-?2-?propyn-?1-?ylamino]?-?N-?(3-?pyridinylmethyl)?-Benzamide
More...
  • Experimental Physico-chemical Properties
  • Miscellaneous

    • Bio Activity:

      CB30865(ZM 242421) is a potent inhibitor of Nampt , an enzyme present in the NAD biosynthetic pathway. MedChem Express http://www.medchemexpress.com/cb-300919.html
      CB30865(ZM 242421) is a potent inhibitor of Nampt , an enzyme present in the NAD biosynthetic pathway. ;IC50 value:;Target: NamptCancer cells develop dependence on Nampt due to increased energy requirements and the elevated activity of NAD consuming enzymes such as sirtuins and mono and poly(ADP-ribose) polymerases (PARPs). These findings suggest new chemical starting points for Nampt inhibitors and further implicate this enzyme as a target in cancer. MedChem Express HY-14373
      Metabolic Enzyme/Protease; MedChem Express HY-14373
      Nampt MedChem Express HY-14373

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module, version: 14.00

Density: 1.4±0.1 g/cm3
Boiling Point:
Vapour Pressure:
Enthalpy of Vaporization:
Flash Point:
Index of Refraction: 1.660
Molar Refractivity: 137.2±0.5 cm3
#H bond acceptors: 7
#H bond donors: 2
#Freely Rotating Bonds: 8
#Rule of 5 Violations: 1
ACD/LogP: 3.70
ACD/LogD (pH 5.5): 3.61
ACD/BCF (pH 5.5): 316.84
ACD/KOC (pH 5.5): 2064.67
ACD/LogD (pH 7.4): 3.67
ACD/BCF (pH 7.4): 362.54
ACD/KOC (pH 7.4): 2362.46
Polar Surface Area: 87 Å2
Polarizability: 54.4±0.5 10-24cm3
Surface Tension: 50.8±7.0 dyne/cm
Molar Volume: 371.7±7.0 cm3

Click to predict properties on the Chemicalize site


Advertisement